FAKTOR OPTIONSSCHEIN - AMBU Stock

Certificat

DE000PN3AMB2

Market Closed - Deutsche Boerse AG 10:21:01 2024-07-05 am EDT
20.42 EUR +0.89% Intraday chart for FAKTOR OPTIONSSCHEIN - AMBU
Current month+7.99%
1 month+10.68%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-05 20.42 +0.89%
24-07-04 20.24 -0.98%
24-07-03 20.44 +1.79%
24-07-02 20.08 -0.15%
24-07-01 20.11 +6.35%

Delayed Quote Deutsche Boerse AG

Last update July 05, 2024 at 10:21 am EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying AMBU A/S
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN3AMB
ISINDE000PN3AMB2
Date issued 2022-05-04
Strike 138 kr
Maturity Unlimited
Parity 1 : 1
Emission price 50
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 57.99
Lowest since issue 3.24
Spread 0.94
Spread %4.36%

Company Profile

Ambu A/S is specialized in the design, production and marketing of medical supplies. Net sales break down by family of products as follows: - single-use endoscopes (56.3%); - emergency care and resuscitation devices (22.9%): mechanical ventilation devices (insufflators, laryngeal masks, facial masks and respiratory bags), secretion aspirators, immobilization devices, etc. In addition, the group sells dummies for first aid training centers; - monitoring and diagnostic devices (20.8%): including electrodes used in the fields of cardiology, neurophysiology and first aid. At the end of September 2023, Ambu A/S had four production sites located in China, Malaysia, the United States and Mexico. Net sales are distributed geographically as follows: Denmark (1.2%), Europe (37.8%), the United States (49.5%), North America (1.3%) and other (10.2%).
Sector
-
More about the company

Ratings for Ambu A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Ambu A/S

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
138 DKK
Average target price
117 DKK
Spread / Average Target
-15.22%
Consensus